Daphne Lainson profiled in Managing IP
Daphne Lainson, principal and leader of the Life Sciences and Bio/Chem practice group recently shared her unique perspective on navigating complex patent landscapes and her commitment to helping clients protect and maximize their intellectual assets in an interview with Managing IP (MIP).
Daphne’s deep understanding of the intersection between technology and IP law is driving significant value for her clients. The most exciting part of her role is making a tangible impact by helping clients navigate complex issues and successfully bring lifesaving or life-changing drugs to Canada.
Her innovative approach and strategic expertise in intellectual property law are setting benchmarks in the industry.
Read the full article on MIP.
Related News & Media
-
Navigating the grey zone: Jean-Sébastien Dupont on GenAI and Canadian copyright law with Canadian Lawyer
In a recent article published by Canadian Lawyer, Jean-Sébastien Dupont discusses the challenges introduced by generative AI in the context of Canadian copyright law.Read More -
Graham Hood on Canadian brand owners’ response to US trade policies
Recently, Graham Hood, the firm’s Trademarks Practice Group Leader, spoke with Rani Mehta of Managing IP about Canadian brand owners’ response to the US political climate.Read More -
Melanie Szweras on certifying data breach class actions for Lexpert
Recently, Principal Melanie Szweras spoke with Jessica Mach from Lexpert on some of the challenges that arise in certifying data breach class actions.Read More